John Lavallee
⚠️ High Risk
FEI: 3003842135 • St Ambroise, MB • CANADA
FEI Number
3003842135
Location
St Ambroise, MB
Country
CANADAAddress
Box 23 Mb, , St Ambroise, MB, Canada
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 12/6/2002 | 66TCB01ALLOPURINOL (XANTHINE OXIDASE INHIBITOR) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 12/6/2002 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 12/6/2002 | 64BCB24FUROSEMIDE (DIURETIC) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 12/6/2002 | 64BCB25HYDROCHLOROTHIAZIDE (DIURETIC) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 12/6/2002 | 62OCB34FOSINOPRIL SODIUM (ANTI-HYPERTENSIVE - PART II) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 12/6/2002 | 63FCB06DIGOXIN (CARDIOTONIC) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 12/6/2002 | 61JCF11GEMFIBROZIL (ANTI-CHOLESTEREMIC) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 12/6/2002 | 63BCQ25FLUTICASONE PROPIONATE (BRONCHODILATOR) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 12/6/2002 | 64UCB06FINASTERIDE (INHIBITOR (DECARBOXYLASE)) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 12/6/2002 | 61ECQ11SALMETEROL XINAFOATE (ANTI-ASTHMATIC) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 12/6/2002 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 12/6/2002 | 61JCB13PRAVASTATIN SODIUM (ANTI-CHOLESTEREMIC) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 12/6/2002 | 62OCF12VALSARTAN (ANTI-HYPERTENSIVE - PART II) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 12/5/2002 | 66SCQ22DIPYRIDAMOLE (VASODILATOR) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
Frequently Asked Questions
What is John Lavallee's FDA import refusal history?
John Lavallee (FEI: 3003842135) has 14 FDA import refusal record(s) in our database, spanning from 12/5/2002 to 12/6/2002.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. John Lavallee's FEI number is 3003842135.
What types of violations has John Lavallee received?
John Lavallee has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about John Lavallee come from?
All FDA import refusal data for John Lavallee is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.